New bioinformatics businesses bloomed over the past year in spite of a challenging market and encroachment from instrument vendors and other larger entities.
The new challenge focuses on computational methods for identifying blood gene expression signatures that can be used as markers of smoking exposure.
Participants in the three-day hackathon, to be held early next year, will develop tools for analyzing NGS data in the context of specific research questions.
The study demonstrated the efficacy of using the Oxford Nanopore MinIon and a bespoke computational pipeline to perform metagenomics testing of viral infections in patients.
Congenica and Omicia have signed contracts to interpret data from the first 8,000 patients in the UK's 100,000 Genomes Project.
Roughly a quarter of the five-year investment will support existing and new biomedical and health research efforts to improve patient care and personalize treatments.
The new center will provide a common space for scientists from various disciplines to work on computational and statistical challenges.
As newly-minted GenoFAB mulls commercial models for its GenoCAD DNA design web app, the company is trying to engage with its target market through pilot projects.
The developers of a web-based tool originally designed to track flu virus evolution have released versions of their software that track changes in other troublesome viruses.
The graph-based tools will allow researchers to query large datasets and identify defining patterns of variation across cancer types and subtypes.
The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.
The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.
News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.
In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.